205 related articles for article (PubMed ID: 25912755)
1. Pseudocarcinomatous hyperplasia associated with primary lymphoma in the urinary bladder: a case report.
Montironi R; Santoni M; Goteri G; Mazzucchelli R; Lopez-Beltran A; Cheng L; Scarpelli M
Hum Pathol; 2015 Jul; 46(7):1040-4. PubMed ID: 25912755
[TBL] [Abstract][Full Text] [Related]
2. Pseudocarcinomatous urothelial hyperplasia of the bladder: clinical findings and followup of 70 patients.
Kryvenko ON; Epstein JI
J Urol; 2013 Jun; 189(6):2083-6. PubMed ID: 23228381
[TBL] [Abstract][Full Text] [Related]
3. Pseudoangiosarcomatous urothelial carcinoma of the urinary bladder.
Paner GP; Cox RM; Richards K; Akki A; Gokden N; Lopez-Beltran A; Krausz T; McKenney JK; Steinberg GD
Am J Surg Pathol; 2014 Sep; 38(9):1251-9. PubMed ID: 25133708
[TBL] [Abstract][Full Text] [Related]
4. Pseudocarcinomatous hyperplasia of the urinary bladder.
Wu A
Arch Pathol Lab Med; 2014 Oct; 138(10):1268-71. PubMed ID: 25268187
[TBL] [Abstract][Full Text] [Related]
5. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.
Gordetsky J; Epstein JI
Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758
[TBL] [Abstract][Full Text] [Related]
6. Pseudocarcinomatous epithelial hyperplasia in the bladder unassociated with prior irradiation or chemotherapy.
Lane Z; Epstein JI
Am J Surg Pathol; 2008 Jan; 32(1):92-7. PubMed ID: 18162775
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of the reduction of UT-B expression in urothelial carcinoma of the bladder.
Li C; Xue H; Lei Y; Zhu J; Yang B; Gai X
Pathol Res Pract; 2014 Dec; 210(12):799-803. PubMed ID: 25445116
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
Guo CC; Fine SW; Epstein JI
Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
[TBL] [Abstract][Full Text] [Related]
9. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
10. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis.
Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L
Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762
[TBL] [Abstract][Full Text] [Related]
11. ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology.
Amin MB; McKenney JK; Paner GP; Hansel DE; Grignon DJ; Montironi R; Lin O; Jorda M; Jenkins LC; Soloway M; Epstein JI; Reuter VE;
Eur Urol; 2013 Jan; 63(1):16-35. PubMed ID: 23083804
[TBL] [Abstract][Full Text] [Related]
12. Utility of uroplakin II expression as a marker of urothelial carcinoma.
Tian W; Guner G; Miyamoto H; Cimino-Mathews A; Gonzalez-Roibon N; Argani P; Li X; Sharma R; Subhawong AP; Rezaei K; Bivalacqua TJ; Epstein JI; Bishop JA; Netto GJ
Hum Pathol; 2015 Jan; 46(1):58-64. PubMed ID: 25449628
[TBL] [Abstract][Full Text] [Related]
13. Value of GATA3 immunostaining in tumor diagnosis: a review.
Ordóñez NG
Adv Anat Pathol; 2013 Sep; 20(5):352-60. PubMed ID: 23939152
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic pitfalls of rare urinary bladder tumors: differential diagnosis of lymphoma-like carcinoma of the bladder--a clinicopathologic study and literature review.
Wronski S; Marszalek A
J Clin Oncol; 2011 Mar; 29(8):e196-9. PubMed ID: 21189383
[No Abstract] [Full Text] [Related]
15. Plasmacytoid urothelial carcinoma of the bladder.
Kohno T; Kitamura M; Akai H; Takaha M; Kawahara K; Oka T
Int J Urol; 2006 Apr; 13(4):485-6. PubMed ID: 16734884
[TBL] [Abstract][Full Text] [Related]
16. Lipoid-cell variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of five cases.
Leroy X; Gonzalez S; Zini L; Aubert S
Am J Surg Pathol; 2007 May; 31(5):770-3. PubMed ID: 17460462
[TBL] [Abstract][Full Text] [Related]
17. Malignant lymphoma case with urinary cytology mimicking that of urothelial carcinoma.
Takahashi H; Shimazaki H; Oda T; Endo H; Sekitsuka H; Maekawa K; Katsurada Y; Sato K; Ito K; Nakanishi K; Tamai S
Cytopathology; 2013 Dec; 24(6):412-4. PubMed ID: 23078009
[No Abstract] [Full Text] [Related]
18. CD138-positive plasmacytoid urothelial carcinoma of the bladder.
Patriarca C; Di Pasquale M; Giunta P; Bergamaschi F
Int J Surg Pathol; 2008 Apr; 16(2):215-7. PubMed ID: 18417684
[No Abstract] [Full Text] [Related]
19. Immunohistochemical Differentiation of Plasmacytoid Urothelial Carcinoma From Secondary Carcinoma Involvement of the Bladder.
Borhan WM; Cimino-Mathews AM; Montgomery EA; Epstein JI
Am J Surg Pathol; 2017 Nov; 41(11):1570-1575. PubMed ID: 28786878
[TBL] [Abstract][Full Text] [Related]
20. Nest-like features in bladder, simulating the nested variant of urothelial carcinoma.
Patriarca C; Colecchia M; Lopez-Beltran A; Sirugo G; Di Pasquale M; Bollito E
Int J Surg Pathol; 2011 Feb; 19(1):11-9. PubMed ID: 20034978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
